Thea

Thea Pharma Inc. Launches IYUZEH™ (latanoprost ophthalmic solution) 0.005% in the U.S.

Retrieved on: 
Tuesday, September 26, 2023

WALTHAM, Mass., Sept. 26, 2023 /PRNewswire/ -- Thea Pharma Inc. ("Thea"), the U.S. subsidiary of Europe's leading independent ophthalmic-focused pharmaceutical company, Théa, dedicated to the research, development, and commercialization of ophthalmic products, today announced the launch and availability of IYUZEH™ (latanoprost ophthalmic solution) 0.005% in the U.S. market. Preservative-free latanoprost, launched over ten years ago, is available in 46 countries, mostly under the brand name MONOPROST®, with about 1.5 million patients treated monthly.1 IYUZEH is the first and only preservative-free latanoprost for patients with primary open-angle glaucoma (POAG) and ocular hypertension (OHT) in the U.S. In randomized, controlled clinical trials of patients with POAG or OHT with mean baseline intraocular pressure (IOP) of 19-24 mmHg, IYUZEH lowered IOP by 3–8 mmHg compared to 4–8 mmHg by XALATAN®.2-4  

Key Points: 
  • "Glaucoma is a chronic eye disease that affects the everyday lives of more than 60 million people globally.
  • With IYUZEH now available, eye care providers can effectively treat their POAG and OHT patients with preservative-free latanoprost.
  • "With the launch of IYUZEH in the U.S., Thea is responding to an important unmet need in the treatment landscape.
  • The Thea Savings Card is available to those commercially insured and not enrolled in a state or federally funded program.

Thea Pharma Inc. Launches Preservative Freedom Coalition to Advocate for Preservative-free Eye Care

Retrieved on: 
Tuesday, May 30, 2023

WALTHAM, Mass., May 30, 2023 /PRNewswire/ -- Thea Pharma Inc. ("Thea"), the U.S. subsidiary of Europe's leading independent ophthalmic-focused pharmaceutical company, Laboratoires Théa, today announced the launch of the Preservative Freedom Coalition to raise awareness of unmet needs in ocular surface disease and opportunities to pursue preservative-free topical ophthalmic medications. In addition to Thea, founding members of this company- and brand-agnostic initiative include: The Glaucoma Foundation, The Intrepid Eye Society, National Medical Association Ophthalmology Section, and Real World Ophthalmology.

Key Points: 
  • The Preservative Freedom Coalition will put the topic of preservative-free eye care in focus through education to eye care professionals and patients.
  • "The eye care industry has a long history of using preservatives in eye drops that persists to this day.
  • "The Preservative Freedom Coalition has the potential to make a significant impact on the education of the entire eye care community and to elevate the awareness of the deleterious effect of preservatives on the ocular surface."
  • "We look forward to working with colleagues across the ophthalmologic, optometric, medical, and pharmaceutical communities as part of the Preservative Freedom Coalition to achieve this shared vision."

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need

Retrieved on: 
Wednesday, March 29, 2023

Furthermore, TOI will invest into Galimedix, thereby demonstrating its strong interest in the Galimedix pipeline, including in Alzheimer’s disease (AD).

Key Points: 
  • Furthermore, TOI will invest into Galimedix, thereby demonstrating its strong interest in the Galimedix pipeline, including in Alzheimer’s disease (AD).
  • Also, the company has received supportive FDA feedback to continue the development through Phase 2 or Phase 2/3.
  • The first patient is planned to be enrolled in 2024, with initial clinical efficacy results expected about 18 months later.
  • In dry AMD, toxic Aβ aggregates cause retinal cells in the central area (the macula) to slowly degenerate and die.

Thea Dudley Joins Suppli as the Company's First Brand Ambassador

Retrieved on: 
Tuesday, February 7, 2023

AUSTIN, Texas, Feb. 7, 2023 /PRNewswire/ -- Suppli, the digital accounts receivable platform that enables construction suppliers to turn their credit department into a competitive advantage, today announced that Thea Dudley has partnered with the Company as a brand ambassador.

Key Points: 
  • Thea has over 30 years of experience in construction credit and collections including executive roles at SRS Distribution and Guardian Building Products.
  • A published author, public speaker and industry consultant, Thea routinely engages with the nation's top construction suppliers and vendors to build and implement modern, technology-enabled credit departments.
  • More than just getting paid faster, it's about enabling your credit team to deliver a differentiated customer experience that makes you the go-to vendor for your accounts," said Thea Dudley.
  • "Thea has been an ally of Suppli since the company's inception so we couldn't be more excited to welcome the "Credit Overlord" herself to the team," said Ryan Ayers, Suppli co-founder.

BrightHR appoints new Chief International Growth and Marketing Officer

Retrieved on: 
Friday, November 11, 2022

MANCHESTER, England, Nov. 11, 2022 /PRNewswire/ -- BrightHR is pleased to announce the appointment of Thea Watson as Chief International Growth and Marketing Officer.

Key Points: 
  • MANCHESTER, England, Nov. 11, 2022 /PRNewswire/ -- BrightHR is pleased to announce the appointment of Thea Watson as Chief International Growth and Marketing Officer.
  • She will work closely with both the executive and marketing functions at BrightHR, a global HR tech company supporting over 85,000 organisations.
  • Thea brings more than 15 years strategic marketing experience to the role.She joins BrightHR from Hays, where she spent 10 years, most recently as Global Customer Experience Director.
  • Alan Price, CEO at BrightHR, says: "We are delighted to welcome Thea to the Senior Leadership Team at BrightHR.

'Secrets of Shape-Shifting Proteins Revealed': Real-time observation of life at the smallest scale, shows how vibrations are used by proteins to change shapes and functions

Retrieved on: 
Thursday, November 3, 2022

DUBAI, UAE, Nov. 4, 2022 /PRNewswire/ -- RAM Medical Corporation L.L.C. (RMC), based in UAE and Germany, has recently set up its headquarters in Dubai. For the past several years, RMC has been developing the next generation of biosensors for biomedical applications. As of October 2022, RMC innovation has created an IP portfolio of more than 60 sensor patents and operates its R&D facilities, cleanrooms, and research labs in Germany. The Company has developed a revolutionary 3D biomolecular mapping platform called ThEA™ (Terahertz Express Analyzer) for real-time 3D imaging of proteins in hopes of radically changing the drug development and personalized diagnostics industries.

Key Points: 
  • RMC has been at the forefront of biotechnology breakthroughs in 3D structural imaging on the atomic scale.
  • RMC's biomolecular imaging platform ThEA was the first non-destructive technology to produce three-dimensional (3D) atomic-scale maps of entire portions of proteins in real-time.
  • Recently, RMC announced a critical development that enables the 3D mapping of the entire inner and outer composition of proteins, including their higher-order structures.
  • "We are constantly looking for ways to integrate our technologies to create new product platforms and disruptive applications."

'Secrets of Shape-Shifting Proteins Revealed': Real-time observation of life at the smallest scale, shows how vibrations are used by proteins to change shapes and functions

Retrieved on: 
Thursday, November 3, 2022

DUBAI, UAE, Nov. 3, 2022 /PRNewswire/ -- RAM Medical Corporation L.L.C. (RMC), based in UAE and Germany, has recently set up its headquarters in Dubai. For the past several years, RMC has been developing the next generation of biosensors for biomedical applications. As of October 2022, RMC innovation has created an IP portfolio of more than 60 sensor patents and operates its R&D facilities, cleanrooms, and research labs in Germany. The Company has developed a revolutionary 3D biomolecular mapping platform called ThEA™ (Terahertz Express Analyzer) for real-time 3D imaging of proteins in hopes of radically changing the drug development and personalized diagnostics industries.

Key Points: 
  • RMC has been at the forefront of biotechnology breakthroughs in 3D structural imaging on the atomic scale.
  • RMC's biomolecular imaging platform ThEA was the first non-destructive technology to produce three-dimensional (3D) atomic-scale maps of entire portions of proteins in real-time.
  • Recently, RMC announced a critical development that enables the 3D mapping of the entire inner and outer composition of proteins, including their higher-order structures.
  • "We are constantly looking for ways to integrate our technologies to create new product platforms and disruptive applications."

Polkadex Is Becoming the First Cross-Chain Orderbook-Based DEX Thanks to Its Latest Testnet Release: Thea

Retrieved on: 
Thursday, March 31, 2022

Tortola, British Virgin Islands--(Newsfile Corp. - March 31, 2022) - Thea, Polkadex 's innovative interoperability layer, is now available on the Polkadex testnet.

Key Points: 
  • Tortola, British Virgin Islands--(Newsfile Corp. - March 31, 2022) - Thea, Polkadex 's innovative interoperability layer, is now available on the Polkadex testnet.
  • Following the Polkadex ethos of providing a CEX-like experience but in a noncustodial DEX, Thea's user interface will resemble the deposit and withdrawal functions on centralized exchanges.
  • Therefore, Thea bridges have no central point of attack as they are as decentralized as the Polkadex network itself.
  • Thea is now live on the Polkadex testnet and will be released to the Polkadex mainnet later this year.

TEAMFL Recognizes Sue Chrzan, Tampa Hillsborough Expressway Authority (THEA) Director of Public Affairs, with Bob Hartnett Leadership Award

Retrieved on: 
Friday, June 4, 2021

TAMPA, Fla., June 4, 2021 /PRNewswire-PRWeb/ --The Transportation and Expressway Authority Membership of Florida (TEAMFL) recognized Sue Chrzan, Director of Communications and Public Affairs at the Tampa Hillsborough Expressway Authority (THEA), with their most prestigious award, the Bob Hartnett Leadership Award.

Key Points: 
  • TAMPA, Fla., June 4, 2021 /PRNewswire-PRWeb/ --The Transportation and Expressway Authority Membership of Florida (TEAMFL) recognized Sue Chrzan, Director of Communications and Public Affairs at the Tampa Hillsborough Expressway Authority (THEA), with their most prestigious award, the Bob Hartnett Leadership Award.
  • She takes a grassroots approach with public outreach and does an amazing job humanizing the agency.
  • She and THEA set the standard of how to be a good community partner," says Brady Nepple, Executive Director, TEAMFL.
  • Sue Chrzan has served as the Director of Public Affairs for the past fifteen years at THEA, Tampa Bay's local tolling agency.

THEA Connected Vehicle Pilot Tests Lifesaving Applications at American Center of Mobility

Retrieved on: 
Thursday, May 27, 2021

The Pilot successfully completed its first three phases of planning, deployment, and real-time data collection and this is an important step to deploying in Tampa.

Key Points: 
  • The Pilot successfully completed its first three phases of planning, deployment, and real-time data collection and this is an important step to deploying in Tampa.
  • "The THEA CV Pilot has been successful in implementing CV technology for sending warnings in real-time and documenting the data for use by the industry for future deployments.
  • THEA's CV Pilot was one of the first of its kind to recruit actual drivers for real-time data on the CV experience.
  • If interested, please learn more about the THEA CV Pilot, please visit our website theacvpilot.com.